160 related articles for article (PubMed ID: 11113924)
1. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
2. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
Seidel P; Seidel A; Herbarth O
Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
[TBL] [Abstract][Full Text] [Related]
3. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
[TBL] [Abstract][Full Text] [Related]
5. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
6. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
8. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
9. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
[TBL] [Abstract][Full Text] [Related]
10. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
[TBL] [Abstract][Full Text] [Related]
11. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
[TBL] [Abstract][Full Text] [Related]
12. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
13. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
[TBL] [Abstract][Full Text] [Related]
14. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
[TBL] [Abstract][Full Text] [Related]
15. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
[TBL] [Abstract][Full Text] [Related]
16. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
Fischbein A; Sharma OK; Selikoff IJ; Borek E
Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
[TBL] [Abstract][Full Text] [Related]
20. A fast capillary electrophoresis method for separation and quantification of modified nucleosides in urinary samples.
Jiang Y; Ma Y
Anal Chem; 2009 Aug; 81(15):6474-80. PubMed ID: 19552424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
